Determinants and prognoses of locoregional and distant progression in breast cancer.
about
Lapatinib for metastatic breast cancer overexpressing HER2Breast cancer in the personal genomics eraCancer survival analysis in Hamburg 1995-2003: assessing the data quality within a population-based registry.Prognostic factors affecting the outcome of brain metastases from breast cancer.Trastuzumab in the adjuvant treatment of HER2-positive early breast cancer patients: a meta-analysis of published randomized controlled trials.Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatment.Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of deathBreast cancer metastasis to the central nervous systemThe prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastasesA novel preclinical method to quantitatively evaluate early-stage metastatic events at the murine blood-brain barrierTherapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier.Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases.c-myc amplifications in primary breast carcinomas and their local recurrences.Comparison of nine prognostic scores in patients with brain metastases of breast cancer receiving radiotherapy of the brain.Organ-specific adaptive signaling pathway activation in metastatic breast cancer cellsPhosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases.Treatment of Breast Cancer Brain Metastases.Immunohistochemical assessment of primary breast tumors and metachronous brain metastases, with particular regard to differences in the expression of biological markers and prognosisPopulation-Based Effects of Mammography Screening in Bavaria on the Distribution of TNM-T Categories with Respect to Different Histological Subgroups.A review of lapatinib ditosylate in the treatment of refractory or advanced breast cancer.Breast cancer subtypes and survival in patients with brain metastasesCranial computed tomographic findings in Nigerian women with metastatic breast cancerTrastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients.A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases.Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastasesSurvival among women with triple receptor-negative breast cancer and brain metastases.Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgeryLuminal B breast cancer: patterns of recurrence and clinical outcome.True local recurrences do not metastasize.Radiation therapy in the prevention of brain metastases.Deep sequencing reveals the mitochondrial DNA variation landscapes of breast-to-brain metastasis blood samples.Effect of Oncoxin Oral Solution in HER2-Overexpressing Breast Cancer.A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients.The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model.Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome.Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis.Central nervous system metastases in women with HER-2 positive metastatic breast cancer after treatment with trastuzumab
P2860
Q24203605-B39A121F-A384-4262-9AD6-89288A31A2E7Q24602679-7FE83312-0C80-4694-8F4C-DEE996442DBAQ31161889-44228BA9-C5A3-4B9D-81DE-D1F8ACAD3A2CQ33238114-2569164B-B474-40AD-A968-C5B67B856A01Q33939795-383E566F-DCB3-44FC-8108-EE6931A4E4A1Q33953465-5028ABA2-94CA-446D-BDEA-D481A26DABAFQ34022312-FD454539-5D25-497B-8392-CC62E0B79D0DQ34455205-1FF62CFF-197F-431D-BF9B-3160E675EA36Q34696334-F40F49BD-967A-49BD-81E1-864616D6C534Q35030625-2AEFFB05-5E5F-4364-8861-C4369D198125Q35608531-CCD37EE2-9580-458C-8694-D3C6E8B03902Q35653866-E06C6FA1-BFD8-4B5B-978D-65FC2A0B4D74Q35769894-24F1F312-3458-48B4-9D04-1AD5E3686C59Q35794600-17CF2F0D-F2B0-4351-BDE2-5DF02FD2BBE3Q35828652-89E4C8AA-9681-4CBC-91EE-CEE975CD2C7EQ35889638-20D5D91C-427C-4371-A227-DBFD80456EB7Q36057858-578D9499-C859-47DF-841C-4263C9858CB1Q36244120-C33EC3A1-12D9-4030-BDFE-73336FABD14FQ36449276-2E51DC32-16F2-43D6-BC41-CA93F4749146Q36642955-A1FEDFE9-254E-4188-B95E-074B91757F08Q36643116-A6C33074-6601-4D13-9206-FF5E097C7E61Q36943619-7A40C96C-1DF7-4E5D-A4F7-CF5405F8C5A0Q37141921-BBCB7DD9-1611-4116-9404-D50857557E1BQ37172818-E4E5F68C-3A09-4039-9E81-CF7AF10D0D58Q37284300-0BE2B440-DE7E-4082-B63F-848C463FCD72Q37293398-7F4A5A35-E84E-4002-971E-BF27BED2A513Q37366712-E6C74577-4C8A-48A4-B53C-A976C55AB492Q37662184-135B3393-BB9F-43A9-95C9-CF8C08C5E265Q37832441-F1A77D3C-81A9-498B-AD61-E598F930A70BQ37963788-EDBA46E5-FE68-4C06-9B5F-A09EFF39BA9FQ38369233-10DC094E-2C50-421C-84AE-97A512ED8FE7Q38846435-B7C5CBB4-4723-4DE9-BDFF-0E7A409BEE28Q40376083-5FA0E51C-A7DB-42A2-BBF8-AFCCD4850FDBQ43786532-8926B888-FB4A-4298-B69F-81E35E3DFEBDQ48220922-5E0927F2-61BD-4EB8-A3D5-92640867939BQ48614511-3DC327C4-A8D6-4C43-9295-E631E06271DFQ57265728-BEB8CF66-D4DE-4F4B-B078-BA05203A7F8B
P2860
Determinants and prognoses of locoregional and distant progression in breast cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Determinants and prognoses of locoregional and distant progression in breast cancer.
@en
type
label
Determinants and prognoses of locoregional and distant progression in breast cancer.
@en
prefLabel
Determinants and prognoses of locoregional and distant progression in breast cancer.
@en
P2093
P1476
Determinants and prognoses of locoregional and distant progression in breast cancer.
@en
P2093
Anne Schlesinger-Raab
Jacqueline Kerr
Jutta Engel
P Dirschedl
Renate Eckel
Sibel Aydemir
Ulker Aydemir
P304
P356
10.1016/S0360-3016(02)04476-0
P407
P577
2003-04-01T00:00:00Z